Koyfin Home > Directory > Health Care > Aimmune Therap > Total Debt / Equity

Aimmune Therap Total Debt / Equity Chart (AIMT)

Aimmune Therap annual/quarterly Total Debt / Equity from 2018 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Aimmune Therap Total Debt / Equity for the quarter ending June 06, 2020 was $80m a 56.33% increase of 45m year over year
  • Aimmune Therap Total Debt / Equity for the last 12 months ending June 06, 2020 was $80m a 56.33% increase of 45m year over year
  • Aimmune Therap Annual Total Debt / Equity for 2019 was $52m a 99.95% increase of 52m from 2018
  • Aimmune Therap Annual Total Debt / Equity for 2018 was $0m
Other Ratios Metrics:
  • Aimmune Therap Total Debt / Capital for the quarter ending December 12, 2017 was $0m
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
View Chart On Koyfin

Quarterly AIMT Total Debt / Equity Data

06/2020$80m
03/2020$60m
12/2019$52m
09/2019$35m
06/2019$25m
03/2019$20m
12/2018$0m

Annual AIMT Total Debt / Equity Data

2019$52m
2018$0m